These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19493071)

  • 1. Commentary: innovation policy for a new era.
    Kapczynski A
    J Law Med Ethics; 2009; 37(2):264-8. PubMed ID: 19493071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-card patent extensions as a means to incentivize research and development of antibiotics.
    Sonderholm J
    J Law Med Ethics; 2009; 37(2):240-6. PubMed ID: 19493069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction: pharmaceutical innovation: law & the public's health.
    Outterson K
    J Law Med Ethics; 2009; 37(2):173-5. PubMed ID: 19493064
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the options.
    Reichman JH
    J Law Med Ethics; 2009; 37(2):247-63. PubMed ID: 19493070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is India ready to lead the battle for fair access to medicines?
    Lancet Oncology
    Lancet Oncol; 2013 May; 14(6):437. PubMed ID: 23639313
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
    Bird RC
    J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to drugs: the case of Abbott in Thailand.
    Cawthorne P; Ford N; Wilson D; Kijtiwatchakul K; Purahong V; Tianudom N; Nacapew S
    Lancet Infect Dis; 2007 Jun; 7(6):373-4. PubMed ID: 17521589
    [No Abstract]   [Full Text] [Related]  

  • 9. Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules.
    Lybecker KM; Fowler E
    J Law Med Ethics; 2009; 37(2):222-39. PubMed ID: 19493068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global impact of Indian generics on access to health.
    Ravinetto RM; Dorlo TP; Caudron JM; Prashanth NS
    Indian J Med Ethics; 2013; 10(2):118-20. PubMed ID: 23697493
    [No Abstract]   [Full Text] [Related]  

  • 11. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 12. Eliminating innovation: how price controls limit access.
    Ingram J
    J Leg Med; 2011 Jan; 32(1):115-28. PubMed ID: 21391059
    [No Abstract]   [Full Text] [Related]  

  • 13. Global pharmaceutical development and access: critical issues of ethics and equity.
    Lage A
    MEDICC Rev; 2011 Jul; 13(3):16-22. PubMed ID: 21778954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 15. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug patent protection: how long is long enough?
    Sibbald B
    CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146
    [No Abstract]   [Full Text] [Related]  

  • 17. A tragically naive Canadian law for tragically neglected global health.
    Attaran A
    CMAJ; 2007 Jun; 176(12):1726-7. PubMed ID: 17449707
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 19. The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?
    Silbermann JM
    J Contemp Health Law Policy; 1996; 12(2):607-36. PubMed ID: 8666736
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent dispute: Delhi High Court gives a boost to access to affordable medicines.
    Menghaney L
    Indian J Med Ethics; 2010; 7(2):97-100. PubMed ID: 20432882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.